Table 1.
Demographic data of study participants reporting receipt of BNT162b2 mRNA vaccine.
| Percentage responded (%) | Number responded (n) | |
|---|---|---|
| Age group (years) | ||
| 18–30 | 7.1% | 57 |
| 31–40 | 38.85% | 312 |
| 41–50 | 29.51% | 237 |
| 51–60 | 16.69% | 134 |
| 61–70 | 7.22% | 58 |
| 71–80 | 0.37% | 3 |
| 81–90 | 0.25% | 2 |
| Gender | ||
| Female | 86.55% | 695 |
| Male | 13.45% | 108 |
| Level of education (answered by 627 HCWs) | ||
| Doctorate or professional medical degree | 58.69% | 368 |
| Master’s degree | 22.97% | 144 |
| Bachelor’s degree | 9.41% | 59 |
| Associate degree | 5.74% | 36 |
| High school graduate (working in healthcare setting) | 3.19% | 20 |
HCWs, healthcare workers.